Evaluation of different methods to measure muscle mass and strength in a population with class II/III obesity: A Follow-up Study

Evaluation of different methods to measure muscle mass and strength in a population with class II/III obesity: A Follow-up Study - MUSCLE-II study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53356

Enrollment

Registered

2023-03-09

Start date

2023-06-27

Completion date

Unknown

Last updated

2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

morbide obesitas Obesity Overweight

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Participation in MUSCLE-study

Exclusion criteria

Exclusion criteria: (1) Weight over 204 kg; (2) pregnancy; (3) pacemaker.

Design outcomes

Primary

Measure	Time frame
The main parameters of this study are: lean mass measured by DXA and US. The main endpoint of this study is the validity of the US measurement of lean mass compared to DXA.	—

Secondary

Measure	Time frame
The secondary parameters include: weight loss after surgery, lean mass change after surgery and comorbidities (baseline vs. 1 year after surgery), results of blood tests. Other study parameters are some patient characteristics: - Demographics: sex, age and ethnicity. - Clinical data from the first year follow-up appointment: anthropometric measures, medical history, underlying diseases, medication use, results of blood tests, food-record and questionnaire.	—

Measure

Time frame

The secondary parameters include: weight loss after surgery, lean mass change after surgery and comorbidities (baseline vs. 1 year after surgery), results of blood tests. Other study parameters are some patient characteristics: - Demographics: sex, age and ethnicity. - Clinical data from the first year follow-up appointment: anthropometric measures, medical history, underlying diseases, medication use, results of blood tests, food-record and questionnaire.

—

Countries

Netherlands

Outcome results